# Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

> **NCT07089303** · — · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 750 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment Due to Alzheimer's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07089303
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2029-07
- **Final completion:** 2029-08
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089303, "Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07089303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*